Congenital cytomegalovirus infection: epidemiology, prediction, diagnosis, and emerging treatment options for symptomatic infants

References

• Furui Y, Yamagishi N, Morioka I, et al. Sequence analyses of variable cytomegalovirus genes for distinction between breast milk- and transfusion-transmitted infections in very-low-birth-weight infants. Transfusion. 2018;58:2894–2902.
   PubMed Web of Science ®Google Scholar
• Schupfer PC, Murph JR, Bale JF Jr. Survival of cytomegalovirus in paper diapers and saliva. Pediatr Infect Dis. 1986;5:677–679.
   PubMedGoogle Scholar
• Tanimura K, Tairaku S, Ebina Y, et al. Prediction of congenital cytomegalovirus infection in high-risk pregnant women. Clin Infect Dis. 2017;64:159–165.
   PubMed Web of Science ®Google Scholar
• Li Q, Wang K, Guo W, et al. Cytomegalovirus pneumonia in a patient with T-lymphoblastic leukemia/lymphoma after allogeneic hematopoietic stem cell transplantation: A case report. Medicine (Baltimore). 2019;98:e14221.
   PubMed Web of Science ®Google Scholar
• Effros RB. The silent war of CMV in aging and HIV infection. Mech Ageing Dev. 2016;158:46–52.
   PubMed Web of Science ®Google Scholar
• Dollard SC, Grosse SD, Ross DS. New estimates of the prevalence of neurological and sensory sequelae and mortality associated with congenital cytomegalovirus infection. Rev Med Virol. 2007;17:355–363.
   PubMed Web of Science ®Google Scholar
• Koyano S, Inoue N, Oka A, et al. Screening for congenital cytomegalovirus infection using newborn urine samples collected on filter paper: feasibility and outcomes from a multicentre study. BMJ Open. 2011;1:e000118.
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Lin CY, Sanchez PJ, et al. Effect of ganciclovir therapy on hearing in symptomatic congenital cytomegalovirus disease involving the central nervous system: a randomized, controlled trial. J Pediatr. 2003;143:16–25.
   PubMed Web of Science ®Google Scholar
• Oliver SE, Cloud GA, Sanchez PJ, et al. Neurodevelopmental outcomes following ganciclovir therapy in symptomatic congenital cytomegalovirus infections involving the central nervous system. J Clin Virol. 2009;46(Suppl 4):S22–6.
   PubMed Web of Science ®Google Scholar
• Nishida K, Morioka I, Nakamachi Y, et al. Neurological outcomes in symptomatic congenital cytomegalovirus-infected infants after introduction of newborn urine screening and antiviral treatment. Brain Dev. 2016;38:209–216.
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Jester PM, Sanchez PJ, et al. Valganciclovir for symptomatic congenital cytomegalovirus disease. N Engl J Med. 2015;372:933–943.
   PubMed Web of Science ®Google Scholar
• Ohyama S, Morioka I, Fukushima S, et al. Efficacy of Valganciclovir treatment depends on the severity of hearing dysfunction in symptomatic infants with congenital cytomegalovirus infection. Int J Mol Sci. 2019;20:1388.
   Web of Science ®Google Scholar
• Fukushima S, Morioka I, Ohyama S, et al. Prediction of poor neurological development in patients with symptomatic congenital cytomegalovirus diseases after oral valganciclovir treatment. Brain Dev. 2019;41:743–750.
   PubMed Web of Science ®Google Scholar
• Manicklal S, Emery VC, Lazzarotto T, et al. The “silent” global burden of congenital cytomegalovirus. Clin Microbiol Rev. 2013;26:86–102.
   PubMed Web of Science ®Google Scholar
• Cannon MJ, Schmid DS, Hyde TB. Review of cytomegalovirus seroprevalence and demographic characteristics associated with infection. Rev Med Virol. 2010;20:202–213.
   PubMed Web of Science ®Google Scholar
• Bate SL, Dollard SC, Cannon MJ. Cytomegalovirus seroprevalence in the United States: the national health and nutrition examination surveys, 1988–2004. Clin Infect Dis. 2010;50:1439–1447.
   PubMed Web of Science ®Google Scholar
• Tanimura K, Tairaku S, Morioka I, et al. Universal screening with use of immunoglobulin G avidity for congenital cytomegalovirus infection. Clin Infect Dis. 2017;65:1652–1658.
   PubMed Web of Science ®Google Scholar
• Wang C, Zhang X, Bialek S, et al. Attribution of congenital cytomegalovirus infection to primary versus non-primary maternal infection. Clin Infect Dis. 2011;52:e11–3.
   PubMed Web of Science ®Google Scholar
• Boppana SB, Fowler KB, Britt WJ, et al. Symptomatic congenital cytomegalovirus infection in infants born to mothers with preexisting immunity to cytomegalovirus. Pediatrics. 1999;104:55–60.
   PubMed Web of Science ®Google Scholar
• Ross SA, Fowler KB, Ashrith G, et al. Hearing loss in children with congenital cytomegalovirus infection born to mothers with preexisting immunity. J Pediatr. 2006;148:332–336.
   PubMed Web of Science ®Google Scholar
• Puhakka L, Renko M, Helminen M, et al. Primary versus non-primary maternal cytomegalovirus infection as a cause of symptomatic congenital infection - register-based study from Finland. Infect Dis (Lond). 2017;49:445–453.
   PubMed Web of Science ®Google Scholar
• Yamada H, Tanimura K, Tairaku S, et al. Clinical factor associated with congenital cytomegalovirus infection in pregnant women with non-primary infection. J Infect Chemother. 2018;24:702–706.
   PubMed Web of Science ®Google Scholar
• Bodeus M, Hubinont C, Goubau P. Increased risk of cytomegalovirus transmission in utero during late gestation. Obstet Gynecol. 1999;93:658–660.
   PubMed Web of Science ®Google Scholar
• Enders G, Daiminger A, Bader U, et al. Intrauterine transmission and clinical outcome of 248 pregnancies with primary cytomegalovirus infection in relation to gestational age. J Clin Virol. 2011;52:244–246.
   PubMed Web of Science ®Google Scholar
• Pass RF, Fowler KB, Boppana SB, et al. Congenital cytomegalovirus infection following first trimester maternal infection: symptoms at birth and outcome. J Clin Virol. 2006;35:216–220.
   PubMed Web of Science ®Google Scholar
• Foulon I, Naessens A, Foulon W, et al. Hearing loss in children with congenital cytomegalovirus infection in relation to the maternal trimester in which the maternal primary infection occurred. Pediatrics. 2008;122:e1123–7.
   PubMed Web of Science ®Google Scholar
• de Vries JJ, Vossen AC, Kroes AC, et al. Implementing neonatal screening for congenital cytomegalovirus: addressing the deafness of policy makers. Rev Med Virol. 2011;21:54–61.
   PubMed Web of Science ®Google Scholar
• Kenneson A, Cannon MJ. Review and meta-analysis of the epidemiology of congenital cytomegalovirus (CMV) infection. Rev Med Virol. 2007;17:253–276.
   PubMed Web of Science ®Google Scholar
• Revello MG, Gerna G. Diagnosis and management of human cytomegalovirus infection in the mother, fetus, and newborn infant. Clin Microbiol Rev. 2002;15:680–715.
   PubMed Web of Science ®Google Scholar
• Stagno S, Whitley RJ. Herpesvirus infections of pregnancy. Part I: cytomegalovirus and Epstein-Barr virus infections. N Engl J Med. 1985;313:1270–1274.
   PubMed Web of Science ®Google Scholar
• Pass RF, Stagno S, Myers GJ, et al. Outcome of symptomatic congenital cytomegalovirus infection: results of long-term longitudinal follow-up. Pediatrics. 1980;66:758–762.
   PubMed Web of Science ®Google Scholar
• Dreher AM, Arora N, Fowler KB, et al. Spectrum of disease and outcome in children with symptomatic congenital cytomegalovirus infection. J Pediatr. 2014;164:855–859.
   PubMed Web of Science ®Google Scholar
• Koyano S, Morioka I, Oka A, et al. Congenital cytomegalovirus in Japan: more than 2 year follow up of infected newborns. Pediatr Int. 2018;60:57–62.
   PubMed Web of Science ®Google Scholar
• Kylat RI, Kelly EN, Ford-Jones EL. Clinical findings and adverse outcome in neonates with symptomatic congenital cytomegalovirus (SCCMV) infection. Eur J Pediatr. 2006;165:773–778.
   PubMed Web of Science ®Google Scholar
• Sakamoto A, Moriuchi H, Matsuzaki J, et al. Retrospective diagnosis of congenital cytomegalovirus infection in children with autism spectrum disorder but no other major neurologic deficit. Brain Dev. 2015;37:200–205.
   PubMed Web of Science ®Google Scholar
• Goderis J, De Leenheer E, Smets K, et al. Hearing loss and congenital CMV infection: a systematic review. Pediatrics. 2014;134:972–982.
   PubMed Web of Science ®Google Scholar
• Morton CC, Nance WE. Newborn hearing screening–a silent revolution. N Engl J Med. 2006;354:2151–2164.
   PubMed Web of Science ®Google Scholar
• Sonoyama A, Ebina Y, Morioka I, et al. Low IgG avidity and ultrasound fetal abnormality predict congenital cytomegalovirus infection. J Med Virol. 2012;84:1928–1933.
   PubMed Web of Science ®Google Scholar
• Ebina Y, Minematsu T, Sonoyama A, et al. The IgG avidity value for the prediction of congenital cytomegalovirus infection in a prospective cohort study. J Perinat Med. 2014;42:755–759.
   PubMed Web of Science ®Google Scholar
• Ebina Y, Minematsu T, Morioka I, et al. Rapid increase in the serum cytomegalovirus IgG avidity index in women with a congenitally infected fetus. J Clin Virol. 2015;66:44–47.
   PubMed Web of Science ®Google Scholar
• Revello MG, Lazzarotto T, Guerra B, et al. A randomized trial of hyperimmune globulin to prevent congenital cytomegalovirus. N Engl J Med. 2014;370:1316–1326.
   PubMed Web of Science ®Google Scholar
• Tanimura K, Tairaku S, Deguchi M, et al. Prophylactic intravenous immunoglobulin injections to mothers with primary cytomegalovirus infection. Kobe J Med Sci. 2014;60:E25–9.
   PubMedGoogle Scholar
• Rawlinson WD, Boppana SB, Fowler KB, et al. Congenital cytomegalovirus infection in pregnancy and the neonate: consensus recommendations for prevention, diagnosis, and therapy. Lancet Infect Dis. 2017;17:e177–e88.
   PubMed Web of Science ®Google Scholar
• Morioka I, Sonoyama A, Tairaku S, et al. Awareness of and knowledge about mother-to-child infections in Japanese pregnant women. Congenit Anom (Kyoto). 2014;54:35–40.
   PubMed Web of Science ®Google Scholar
• Nigro G, Adler SP. Congenital Cytomegalic Disease Collaborating Group. High-dose CMV hyperimmune globulin (HIG) and maternal CMV DNAemia independently predict infant outcome in pregnant women with a primary cytomegalovirus (CMV) infection. Clin Infect Dis. 2019. [cited 2019 Oct 20]. DOI:10.1093/cid/ciz1030.
   PubMedGoogle Scholar
• Lazzarotto T, Guerra B, Gabrielli L, et al. Update on the prevention, diagnosis and management of cytomegalovirus infection during pregnancy. Clin Microbiol Infect. 2011;17:1285–1293.
   PubMed Web of Science ®Google Scholar
• Fujioka K, Morioka I, Nishida K, et al. Pulmonary hypoplasia caused by Fetal Ascites in congenital cytomegalovirus infection despite fetal therapy. Front Pediatr. 2017;5:241.
   PubMed Web of Science ®Google Scholar
• Negishi H, Yamada H, Hirayama E, et al. Intraperitoneal administration of cytomegalovirus hyperimmunoglobulin to the cytomegalovirus-infected fetus. J Perinatol. 1998;18:466–469.
   PubMedGoogle Scholar
• Japanese Congenital Cytomegalovirus Infection Immunoglobulin Fetal Therapy Study Group. A trial of immunoglobulin fetal therapy for symptomatic congenital cytomegalovirus infection. J Reprod Immunol. 2012;95:73–79.
   PubMed Web of Science ®Google Scholar
• Leruez-Ville M, Ghout I, Bussieres L, et al. In utero treatment of congenital cytomegalovirus infection with valacyclovir in a multicenter, open-label, phase II study. Am J Obstet Gynecol. 2016;215:462 e1- e10.
   Web of Science ®Google Scholar
• Seidel V, Feiterna-Sperling C, Siedentopf JP, et al. Intrauterine therapy of cytomegalovirus infection with valganciclovir: review of the literature. Med Microbiol Immunol. 2017;206:347–354.
   PubMed Web of Science ®Google Scholar
• Nozawa N, Koyano S, Yamamoto Y, et al. Real-time PCR assay using specimens on filter disks as a template for detection of cytomegalovirus in urine. J Clin Microbiol. 2007;45:1305–1307.
   PubMed Web of Science ®Google Scholar
• Ross SA, Ahmed A, Palmer AL, et al. Detection of congenital cytomegalovirus infection by real-time polymerase chain reaction analysis of saliva or urine specimens. J Infect Dis. 2014;210:1415–1418.
   PubMed Web of Science ®Google Scholar
• de Vries JJ, van der Eijk AA, Wolthers KC, et al. Real-time PCR versus viral culture on urine as a gold standard in the diagnosis of congenital cytomegalovirus infection. J Clin Virol. 2012;53:167–170.
   PubMed Web of Science ®Google Scholar
• Boppana SB, Ross SA, Shimamura M, et al. Saliva polymerase-chain-reaction assay for cytomegalovirus screening in newborns. N Engl J Med. 2011;364:2111–2118.
   PubMed Web of Science ®Google Scholar
• Hamprecht K, Maschmann J, Vochem M, et al. Epidemiology of transmission of cytomegalovirus from mother to preterm infant by breastfeeding. Lancet. 2001;357:513–518.
   PubMed Web of Science ®Google Scholar
• Boppana SB, Ross SA, Novak Z, et al. Dried blood spot real-time polymerase chain reaction assays to screen newborns for congenital cytomegalovirus infection. JAMA. 2010;303:1375–1382.
   PubMed Web of Science ®Google Scholar
• Kobayashi Y, Morioka I, Koda T, et al. Low total IgM values and high cytomegalovirus loads in the blood of newborns with symptomatic congenital cytomegalovirus infection. J Perinat Med. 2015;43:239–243.
   PubMed Web of Science ®Google Scholar
• Lanari M, Lazzarotto T, Venturi V, et al. Neonatal cytomegalovirus blood load and risk of sequelae in symptomatic and asymptomatic congenitally infected newborns. Pediatrics. 2006;117:e76–83.
   PubMed Web of Science ®Google Scholar
• Boppana SB, Fowler KB, Pass RF, et al. Congenital cytomegalovirus infection: association between virus burden in infancy and hearing loss. J Pediatr. 2005;146:817–823.
   PubMed Web of Science ®Google Scholar
• Yamamoto AY, Mussi-Pinhata MM, Marin LJ, et al. Is saliva as reliable as urine for detection of cytomegalovirus DNA for neonatal screening of congenital CMV infection? J Clin Virol. 2006;36:228–230.
   PubMed Web of Science ®Google Scholar
• Choi KY, Schimmenti LA, Jurek AM, et al. Detection of cytomegalovirus DNA in dried blood spots of Minnesota infants who do not pass newborn hearing screening. Pediatr Infect Dis J. 2009;28:1095–1098.
   PubMed Web of Science ®Google Scholar
• Barkai G, Barzilai A, Mendelson E, et al. Newborn screening for congenital cytomegalovirus using real-time polymerase chain reaction in umbilical cord blood. Isr Med Assoc J. 2013;15:279–283.
   PubMed Web of Science ®Google Scholar
• Leruez-Ville M, Vauloup-Fellous C, Couderc S, et al. Prospective identification of congenital cytomegalovirus infection in newborns using real-time polymerase chain reaction assays in dried blood spots. Clin Infect Dis. 2011;52:575–581.
   PubMed Web of Science ®Google Scholar
• Koontz D, Baecher K, Amin M, et al. Evaluation of DNA extraction methods for the detection of cytomegalovirus in dried blood spots. J Clin Virol. 2015;66:95–99.
   PubMed Web of Science ®Google Scholar
• Gantt S, Bitnun A, Renaud C, et al. Diagnosis and management of infants with congenital cytomegalovirus infection. Paediatr Child Health. 2017;22:72–74.
   PubMed Web of Science ®Google Scholar
• Koyano S, Inoue N, Nagamori T, et al. Newborn screening of congenital cytomegalovirus infection using saliva can be influenced by breast feeding. Arch Dis Child Fetal Neonatal Ed. 2013;98:F182.
   PubMed Web of Science ®Google Scholar
• Ross SA, Michaels MG, Ahmed A, et al. Contribution of breastfeeding to false-positive saliva polymerase chain reaction for newborn congenital cytomegalovirus screening. J Infect Dis. 2018;217:1612–1615.
   PubMed Web of Science ®Google Scholar
• Noyola DE, Demmler GJ, Williamson WD, et al. Cytomegalovirus urinary excretion and long term outcome in children with congenital cytomegalovirus infection. Congenital CMV Longitudinal Study Group. Pediatr Infect Dis J. 2000;19:505–510.
   PubMed Web of Science ®Google Scholar
• El Helou G, Razonable RR. Letermovir for the prevention of cytomegalovirus infection and disease in transplant recipients: an evidence-based review. Infect Drug Resist. 2019;12:1481–1491.
   PubMed Web of Science ®Google Scholar
• Kimberlin DW, Acosta EP, Sanchez PJ, et al. Pharmacokinetic and pharmacodynamic assessment of oral valganciclovir in the treatment of symptomatic congenital cytomegalovirus disease. J Infect Dis. 2008;197:836–845.
   PubMed Web of Science ®Google Scholar
• Whitley RJ, Cloud G, Gruber W, et al. Ganciclovir treatment of symptomatic congenital cytomegalovirus infection: results of a phase II study. National Institute of Allergy and Infectious Diseases Collaborative Antiviral Study Group. J Infect Dis. 1997;175:1080–1086.
   PubMed Web of Science ®Google Scholar
• Roche Pharmaceuticals. Valganciclovir package insert. 2017. [cited 2019 Dec 15]. Available from: https://www.roche.com.bd/content/dam/rochexx/roche-com-bd/product-information/Valcyte%20Product%20Information%20_%20FE-English%20Ro%20107-9070_%20July%202017.pdf
   Google Scholar
• McLeroth P, Paduch DA, Abt M, et al. Effects of valganciclovir on spermatogenesis in renal transplant patients - results of a multicenter prospective non-randomized study. Transpl Int. 2019. [cited 2019 Nov 15]. DOI:10.1111/tri.13558.
   PubMed Web of Science ®Google Scholar
• Korndewal MJ, Weltevrede M, van den Akker-van Marle ME, et al. Healthcare costs attributable to congenital cytomegalovirus infection. Arch Dis Child. 2018;103:452–457.
   PubMed Web of Science ®Google Scholar
• Japan Pediatric Society. Cytomegalovirus PCR test using a urine within 3 weeks of life for the diagnosis for congenital cytomegalovirus infection was covered by public insurance. 2018. (In Japanese) [cited 2019 Dec 15]. Available from: https://www.jpeds.or.jp/uploads/files/CMV_sindan201809.pdf
   Google Scholar